Inhibition of proliferation and induction of apoptosis by 25-hydroxyvitamin D3-3beta-(2)-Bromoacetate, a nontoxic and vitamin D receptor-alkylating analog of 25-hydroxyvitamin D3 in prostate cancer cells.

Inhibition of proliferation and induction of apoptosis by 25-hydroxyvitamin D3-3beta-(2)-Bromoacetate, a nontoxic and vitamin D receptor-alkylating analog of 25-hydroxyvitamin D3 in prostate cancer cells. Clin Cancer Res. 2004 Dec 01; 10(23):8018-27.

View in: PubMed

subject areas

25-Hydroxyvitamin D3 1-alpha-Hydroxylase
Animals
Apoptosis
Calcitriol
Carrier Proteins
Caspases
Cell Proliferation
Chloramphenicol O-Acetyltransferase
COS Cells
Dose-Response Relationship, Drug
Enzyme Activation
Humans
Keratinocytes
Male
Mice
Neoplasms, Hormone-Dependent
Nerve Tissue Proteins
Promoter Regions, Genetic
Prostate
Prostatic Neoplasms
Receptors, Calcitriol
Retinoid X Receptors
Thymidine
Tumor Cells, Cultured

authors with profiles

NANCY WEIGEL